Moteur de recherche d’entreprises européennes
Financement de l’UE (3 996 150 €) : FAIRplus Hor01/01/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
FAIRplus
Wide sharing of knowledge and data drives the progression of science. Shared data allows other researchers to reproduce findings and benchmark quality of experiments. Sharing data so that other researchers can Find, Access and Interoperate – i.e. integrate the data with the outcomes of their own experiments - allows Reuse and an opportunity to build the large aggregated cohorts we need to detect rare signals and manage the many confounding factors in translational research. This project will develop the guidelines and tools needed to make data FAIR. Through worked examples using IMI and EFPIA data and application and extension of existing methods we will improve the level of discovery, accessibility, interoperability and reusability of selected IMI and EFPIA data. In addition, through disseminated guidelines and tailored training for data handlers in academia, SMEs and pharmaceuticals, data management culture will change and be sustained and datasets will be reused by pharmaceutical companies, academia and SMEs. Our FAIR SME & Innovation programme will enable wide data reuse and foster an innovation ecosystem around these data that power future re-use, knowledge generation, and societal benefit. We call this approach ‘FAIRplus’.
| Astrazeneca AB | 0,00 € |
| BAYER AG | 0,00 € |
| 0,00 € | |
| Barcelona Supercomputing Center Centro Nacional de Supercomputacion | 190 306 € |
| 855 639 € | |
| Eli Lilly and Company Ltd. | 0,00 € |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | 401 130 € |
| Fundacio Institut Hospital del Mar D Investigacions Mediques | 162 384 € |
| 0,00 € | |
| Heriot-Watt University | 70 488 € |
| Imperial College of Science Technology and Medicine | 235 255 € |
| Institut National de la Sante et de la Recherche Medicale | 0,00 € |
| Janssen Pharmaceutica N.V. | 0,00 € |
| NOVARTIS PHARMA AG | 0,00 € |
| Open Phacts Foundation LBG | 211 938 € |
| SIB SWISS INSTITUTE OF BIOINFORMATICS | 191 838 € |
| Stichting Lygature | 221 544 € |
| 209 435 € | |
| The Chancellor, Masters and Scholars of the University of Oxford | 304 825 € |
| The University of Manchester | 281 418 € |
| Universite DU Luxembourg | 294 038 € |
| Universite Paul Sabatier Toulouse III | 107 514 € |
| Universiteit Maastricht | 258 401 € |
https://cordis.europa.eu/project/id/802750
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Astrazeneca AB - Financement de l’UE (3 996 150 €) : FAIRplus"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
